Skip Navigation


European Heart Journal Advance Access originally published online on February 19, 2008
European Heart Journal 2008 29(5):573-575; doi:10.1093/eurheartj/ehm645
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
29/5/573    most recent
ehm645v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Taggart, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taggart, D. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Does prior PCI increase the risk of subsequent CABG?

David P. Taggart*

University of Oxford, John Radcliffe Hospital, Department of Cardiac Surgery, Oxford OX3 9DU, UK

* Corresponding author. Tel: +44 1865 221121, Fax: +44 1865 220244, Email: David.taggart@orh.nhs.uk

This editorial refers to ‘Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study’ by S. Chocron et al.,{dagger} on page 673

The first 10% of the full text of this article appears below.

Chocron and colleagues have reported that prior percutaneous coronary intervention (PCI) leads to a worse outcome in patients subsequently undergoing coronary artery bypass graft (CABG).1 In view of the fact that around one-third of patients with multivessel disease treated with bare metal stents will require re-intervention within a few years,2 this conclusion is potentially worrying and raises several questions. (i) Is the conclusion justifiable? (ii) Are the findings consistent with other studies in the literature? (iii) If real, what are the likely pathophysiological mechanisms? (iv) Will the findings be different drug-eluting stents? (v) What are the clinical implications for patients and the economic implications for health services?

Is the conclusion justifiable?

The obvious weakness of the study of . . . [Full Text of this Article]

Are the findings consistent with other studies in the literature?

If real, what are the likely pathophysiological mechanisms?

Will the findings be different with drug-eluting stents?

What are the clinical implications for patients and the economic implications for health services?


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study
Sidney Chocron, Richard Baillot, Jean Lucien Rouleau, Wayne J. Warnica, Pierre Block, David Johnstone, Martin G. Myers, Cristina Dana Calciu, Anna Nozza, Pierre Martineau, Wiek H. van Gilst, and for the IMAGINE Investigators
EHJ 2008 29: 673-679. [Abstract] [Full Text]